Galantamine: all 77 studies that test it

Page 1 of 1. Open to participants first (3), then studies with results posted, then the rest; newest registration first within each.

• Pilot Study of Galantamine to Treat Metabolic Syndrome in People With Chronic Traumatic Spinal Cord Injury (SCI)RecruitingNCT07625332Phase 2/3
• Exploration of the Efficacy and Mechanism of Galantamine (an Extract From Lycoris Aurea) in Treating Ischemic StrokeRecruitingNCT07003386Phase 2/3
• Enhancing Parasympathetic Activity to Improve Endothelial Dysfunction, Vascular Oxidative Stress in African AmericansRecruitingNCT04769206Phase 1/2
• Effect of Galantamine on Inflammation and CognitionCompletedNCT03384784Phase 2Results posted
• Low-Dose Galantamine to Potentiate the Attention-Enhancing Effects of Low-Dose NicotineCompletedNCT02420327Not applicableResults posted
• Racial Differences in Vagal Control of Glucose HomeostasisCompletedNCT02365285Phase 1/2Results posted
• Galantamine and Memantine Combination for Cognitive Impairments in SchizophreniaTerminatedNCT02234752Phase 2Results posted
• A Study to Help People Quit Smoking.CompletedNCT01880099Not applicableResults posted
• Effect of Galantamine on Short-term AbstinenceCompletedNCT01669538Phase 2Results posted
• Effect of Galantamine on Smoking AbstinenceCompletedNCT01548638Phase 2Results posted
• Cognitive Enhancement as a Target for Cocaine PharmacotherapyCompletedNCT01531153Not applicableResults posted
• Comparative Research of Alzheimer's Disease DrugsTerminatedNCT01362686Not applicableResults posted
• The CIRCADIAN Study: Evaluation of Modulating Effect of Galantamine on Circadian Rhythm in Patients With Mild to Moderate Alzheimer's DiseaseTerminatedNCT01181921Phase 4Results posted
• Effects of Galantamine on CognitionCompletedNCT01100775Phase 2Results posted
• The Efficacy of Galantamine Treatment on Attention in Patients With Alzheimer's DiseaseCompletedNCT01054976Phase 4Results posted
• Oxytocin or Galantamine Versus Placebo for the Treatment of Negative Symptoms and Cognitive Impairments in SchizophreniaCompletedNCT01012167Phase 2Results posted
• An Efficacy and Safety Study of Galantamine for the Treatment of Patients With Alzheimer's DiseaseCompletedNCT00814801Phase 3Results posted
• Galantamine to Enhance Cognitive Behavioral Therapy for Cocaine AbuseCompletedNCT00809835Phase 2Results posted
• A Study of Galantamine Used to Treat Patients With Mild to Moderate Alzheimer's DiseaseTerminatedNCT00679627Phase 3Results posted
• Galantamine Effects on Cognitive Function in Abstinent Cocaine UsersCompletedNCT00606801Not applicableResults posted
• The Use of Galantamine HBr (Reminyl) in Electroconvulsive Therapy: Impact on Mood and Cognitive FunctioningCompletedNCT00566735Phase 3Results posted
• Use of Galantamine and CDP-choline (Citicoline) to Treat Adults With SchizophreniaCompletedNCT00509067Phase 2Results posted
• Acetylcholinesterase Inhibitors to Improve Cognitive Function and Overall Rehabilitation After a StrokeCompletedNCT00227994Phase 4Results posted
• Efficacy Study of Galantamine for Cognitive Impairments in SchizophreniaCompletedNCT00176423Phase 4Results posted
• Vagal Stimulation in POTSActive, not recruitingNCT03124355Phase 1
• Racial Differences in Vagal Control of Glucose Homeostasis, Chronic StudyWithdrawnNCT03014323Phase 1
• Pharmacovigilance in Gerontopsychiatric PatientsTerminatedNCT02374567Phase 3
• Galantamine Effects in Patients With Metabolic SyndromeCompletedNCT02283242Phase 4
• Symptomatic Treatment of Vascular Cognitive ImpairmentStatus unknownNCT02098824Phase 2/3
• Cognitive Rehabilitation and Galantamine for Post Stroke Cognitive ImpairmentCompletedNCT01508494Phase 2
• Evaluation of Efficacy and Safety of Galantamine in Patients With Dementia of Alzheimer's Type Who Failed to Benefit From DonepezilCompletedNCT01478633Phase 4
• Galantamine Bioequivalence Study of Dr. Reddy's Under Fed ConditionCompletedNCT01372306Phase 1
• Galantamine Bioequivalence Study of Dr. Reddy's Under Fasting ConditionCompletedNCT01372280Phase 1
• Bioequivalence Study of Galantamine 4 mg Tablet and Reminyl Following a 4 mg Dose in Healthy Subjects Under Fed ConditionsCompletedNCT01190761Phase 1
• Bioequivalence Study of Galantamine 4 mg Tablet and Reminyl Following a 4 mg Dose in Healthy Subjects Under Fasting ConditionsCompletedNCT01190748Phase 1
• Galantamine Treatment for Nonfluent Aphasia in Stroke PatientsCompletedNCT01129479Not applicable
• Drug-Drug Interaction to Study the Effect of BMS-708163 on Pharmacokinetics (PK) of Galantamine Extended Release (ER)CompletedNCT01039194Phase 1
• Characteristics of Treatment Responders to GalantamineCompletedNCT01029132Not applicable
• Galantamine Effects on Cognitive Function in Marijuana UsersCompletedNCT00969696Phase 1
• Alzheimer and SleepCompletedNCT00750529Phase 1
• A Single Dose, Cross-over Bioequivence Study Comparing Galantamine IR (Immediate Release) Table and Galantmine OS (Oral Solution) in Healthy VolunteersCompletedNCT00645554Phase 1
• The Relationship Between Risperdal Treatment and Quality of Life in Patients With Alzheimer's Disease and Behavioural and Psychological Symptoms of Dementia (BPSD)Status unknownNCT00626613Phase 4
• Diffusion Tensor Weighted MRI in Alzheimer's Disease Modifying Treatment Effects of Galantamine (Reminyl®)Status unknownNCT00523666Phase 4
• Galantamine for Cognitive Deficits in SchizophreniaCompletedNCT00463879Phase 2/3
• Galantamine Augmentation of Escitalopram for Treatment of DepressionTerminatedNCT00423969Phase 4
• A Pilot Study to Explore the Safety and Tolerability of Galantamine HBr in the Treatment of Pick Complex/Frontotemporal DementiaCompletedNCT00416169Phase 2
• Functional Brain Imaging of Medication Treatment Response in Mild Alzheimer's Disease PatientsTerminatedNCT00369603Phase 4
• Safety and Efficacy of High Dose, Rapid Titration Galantamine in Patients With Alzheimer's DiseaseCompletedNCT00338117Phase 3
• Galantamine for Cognition in People With SchizophreniaCompletedNCT00320736Phase 4
• A Cardiac Safety Study of Galantamine in the Treatment of Alzheimer's Disease.CompletedNCT00309725Phase 3
• Long-term Safety and Efficacy of Galantamine in Alzheimer's DiseaseCompletedNCT00304629Phase 3
• An Efficacy and Safety Study of Galantamine for the Treatment of Patients With Alzheimer's Disease.CompletedNCT00301574Phase 3
• A Study of the Safety and Effectiveness of Galantamine Versus Placebo in the Treatment of Patients With Vascular Dementia or Mixed DementiaCompletedNCT00261573Phase 3
• A Study of the Safety and Effectiveness of a Flexible Dose of Galantamine Versus Placebo in the Treatment of Patients With Alzheimer's DiseaseCompletedNCT00253227Phase 3
• Placebo-Controlled Evaluation of Galantamine in the Treatment of Alzheimer's Disease: Safety and Efficacy of a Controlled-Release FormulationCompletedNCT00253214Phase 3
• A Study of the Safety and Effectiveness of Two Doses of Galantamine Versus Placebo in the Treatment of Patients With Alzheimer's DiseaseCompletedNCT00253201Phase 3
• A Study of the Safety and Effectiveness of Two Doses of Galantamine Versus Placebo in the Treatment of Patients With Alzheimer's DiseaseCompletedNCT00253188Phase 3
• Galantamine Versus Placebo in Childhood AutismCompletedNCT00252603Phase 3
• A Follow-up Study to Assess Safety and Tolerability of Galantamine Treatment in Individuals With Mild Cognitive ImpairmentCompletedNCT00240695Phase 3
• A Study to Evaluate the Efficacy and Safety of Galantamine in Patients With Mild Cognitive ImpairmentCompletedNCT00236574Phase 3
• A Study to Evaluate the Efficacy and Safety of Galantamine in Patients With Mild Cognitive ImpairmentCompletedNCT00236431Phase 3
• Efficacy of Galantamine to Treat SchizophreniaTerminatedNCT00232349Phase 4
• Safety and Efficacy of Galantamine in Patients With Dementia With Lewy BodiesCompletedNCT00230997Phase 3
• Safety Study of Galantamine in Tic DisordersTerminatedNCT00226824Phase 4
• Galantamine in the Treatment of Post-Traumatic HeadacheStatus unknownNCT00219869Phase 4
• Treatment of Severe Alzheimer's Disease: Evaluation of Efficacy and Safety of Galantamine Hydrobromide in a Controlled StudyCompletedNCT00216593Phase 3
• The Efficacy of Galantamine on the Attention and the Frontal Function of the Patients With Dementia of Alzheimer TypeCompletedNCT00216515Phase 4
• A Study of the Safety and Effectiveness of Galantamine in Patients With Alzheimer's DiseaseCompletedNCT00216502Phase 3
• Galantamine Executive Function in Parkinson's DiseaseStatus unknownNCT00211588Not applicable
• A Double-Blind, Placebo-Controlled Study of Galantamine to Improve Cognitive Dysfunction in Bipolar DisorderCompletedNCT00195845Phase 4
• Treatment of Tardive Dyskinesia With GalantamineCompletedNCT00164242Phase 4
• An Open-Label Investigation of the Adjuvant Therapeutic Effects of Galantamine in Patients With Chronic Schizophrenia and Persistent Deficit SymptomsCompletedNCT00161044Not applicable
• Safety and Tolerability Study of Extended Release (ER) Galantamine in Alzheimer's DiseaseCompletedNCT00082602Phase 3
• A Study of the Effectiveness and Safety of Galantamine Hydrobromide on Cognitive Impairment in Patients With Schizophrenia.CompletedNCT00077727Phase 3
• A Study of the Effects on Sleep, Attention, and Gastrointestinal Tolerance of Galantamine and Donepezil in Patients With Alzheimer's DiseaseCompletedNCT00035204Phase 4
• A Placebo-controlled Trial to Evaluate the Safety and Efficacy of Galantamine in the Treatment of Vascular DementiaCompletedNCT00035191Phase 3
• Evaluation of Galantamine in the Treatment of Alzheimer's DiseaseCompletedNCT00000172Phase 3

← Galantamine overview